Domain > www.algernonpharmaceuticals.com

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2023-06-07	54.204.13.102 (ClassC)
2023-09-27	54.145.232.231 (ClassC)
2024-07-19	44.209.57.54 (ClassC)
2024-10-21	184.73.186.24 (ClassC)
2025-05-05	54.183.230.231 (ClassC)
2025-05-09	54.183.187.40 (ClassC)
2025-05-13	54.176.210.180 (ClassC)
2025-05-21	52.8.23.115 (ClassC)
2025-05-25	184.169.227.74 (ClassC)
2025-09-15	35.171.180.101 (ClassC)
2026-01-05	52.53.61.56 (ClassC)
2026-02-04	52.53.80.136 (ClassC)

HTTP/1.1 200 OKDate: Mon, 05 May 2025 11:01:12 GMTServer: ApacheX-Frame-Options: SAMEORIGINStrict-Transport-Security: max-age31536000;X-XSS-Protection: 1; modeblockX-Content-Type-Options: nosniffFeatu

!DOCTYPE html>html langen>    head>        meta http-equivx-ua-compatible contentieedge>        meta charsetutf-8>                        link relalternate typeapplication/rss+xml titleAlgernon Pharmaceuticals Inc. - Recent News hrefhttps://www.algernonpharmaceuticals.com/news-media/news-releases/rss />                        title>Algernon Pharmaceuticals Inc. (AGN)/title>                link relcanonical hrefhttps://www.algernonpharmaceuticals.com>meta propertyog:url contenthttps://www.algernonpharmaceuticals.com>meta propertyog:site_name contentAlgernon Pharmaceuticals Inc.>meta propertyog:title contentAlgernon Pharmaceuticals Inc.>meta propertyog:type contentwebsite>meta propertyog:image contenthttps://d1io3yog0oux5.cloudfront.net/_14e91651207daf7f3a207c1d33874a5b/algernonpharmaceuticals/db/2307/21026/social_image_resized.jpg>meta nametwitter:card contentsummary_large_image>script typeapplication/ld+json>	{@context:http://schema.org,@type:Corporation,name:Algernon Pharmaceuticals Inc.,address:{@type:PostalAddress,streetAddress:601 West Broadway Suite 400,addressLocality:Vancouver, BC,postalCode:V5Z 4C2,addressCountry:Canada},legalName:Algernon Pharmaceuticals Inc.,description:Algernon Pharmaceuticals is a Canadian clinical stage drug development and repurposing company investigating multiple drugs for unmet global medical needs. Algernon Pharmaceuticals is the parent company of a newly created private equity subsidiary called Algernon NeuroScience, that is advancing a program investigating a proprietary form of DMT for stroke and traumatic brain injury (TBI). The Company recently closed on its agreement with Seyltx Inc., a privately owned U.S. based drug development company, for the acquisition of Algernonu2019s NP-120 Ifenprodil research program to treat chronic cough and idiopathic pulmonary fibrosis, and also maintains a research program for chronic kidney disease.,tickerSymbol:: AGN,url:https://www.algernonpharmaceuticals.com,logo:https://d1io3yog0oux5.cloudfront.net/_14e91651207daf7f3a207c1d338

Subdomains

Date	Domain	IP
ir.algernonpharmaceuticals.com	2025-05-05	13.57.74.156
www.algernonpharmaceuticals.com	2025-05-05	54.183.230.231

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > www.algernonpharmaceuticals.com

Is this malicious?

DNS Resolutions

Port 443

Subdomains